Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Since there are also (bad) attempts at pure misinformation from some here, I am pasting Investtech's automatic technical analyses which were updated yesterday 02.12.25. For those who are interested 😉
Automatic technical analysis. Short term, 2. Dec 2025
An approximately horizontal trend channel has been broken upwards in the short term. A continued strong development is indicated, and Thor Medical ASA now has support at any reactions down towards the trend lines. The stock has reached the objective at 4.41 kroner after a breakout from a rectangle formation. The price has now fallen back somewhat, but the formation indicates further upside. The stock has support at approximately 3.76 kroner and resistance at approximately 4.70 kroner. RSI above 70 shows that the momentum in the stock is strongly positive in the short term. Investors have consistently paid higher prices to buy the stock, which indicates increasing optimism and that the price will continue to rise. The stock is considered technically positive overall in the short term.
Recommendation one to six weeks' horizon: Buy (Score: 85)
Automatic technical analysis. Medium term, 2. Dec 2025
Thor Medical ASA shows strong development within a rising trend channel in the medium term. This signals increasing optimism among investors and indicates further price appreciation. The price has risen sharply after a buy signal from an inverse head-and-shoulders formation upon breaking above the resistance at 2.62 kroner. The objective at 3.74 kroner has now been reached, but the formation still signals development in the same direction. The stock is approaching resistance at approximately 4.70 kroner, which may lead to a downward reaction. A breakout above 4.70 kroner will, however, be a buy signal. Volume tops and volume bottoms correspond well with tops and bottoms in the price. This strengthens the trend picture. The RSI curve shows a rising trend, which supports the positive trend picture. The stock is considered technically positive overall in the medium term.
Recommendation one to six months' horizon: Buy (Score: 71)
There are still opinions about share issues and other matters concerning the company.
I recommend everyone who hasn't seen it to spend 15 minutes on Finansavisen-TV's interview with CEO Jasper Kurth from 29.08.25.
https://www.youtube.com/watch?v=RQL7eDEu4wg
Quoting a key point from the CEO:
"I think the most important message here is that we are fully funded to break even"
Good with a few percent discount, this one will go up and forward in the future now that they have entered into a 5-year agreement and have raised a lot of capital last year, so this should be good
The case is good and I don't think one needs to worry about it, so one shouldn't go on the defensive every time it dips a little, I think🤷♂️ Let it run its course, and this will become big.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset ja analyysit
Uutiset ja lehdistötiedotteet
Analyysit
28 marras 07.39
∙
Lehdistötiedote
BioStock: Thor Medical advances toward commercial scale following pilot success and major deal streak
28 marras 07.39
∙
Lehdistötiedote
BioStock: Thor Medical tar klivet mot kommersiell produktion efter framgångsrik pilot och intensiv avtalsperiod
20 marras 12.27
∙
Lehdistötiedote
Thor Medical ASA - New share capital registered
20 marras 06.30
∙
Lehdistötiedote
TRMED: Thor Medical enters supply agreement with NucliThera for thorium-228
18 marras 06.30
∙
Lehdistötiedote
TRMED: Thor Medical strengthens executive team to realise leadership ambitions in targeted alpha therapies
11 marras 22.15
∙
Lehdistötiedote
Thor Medical - Issuance of RSU shares to members of the board
7 marras 07.14
∙
Lehdistötiedote
BioStock: Thor Medical comments on the Telix agreement
7 marras 07.14
∙
Lehdistötiedote
BioStock: Thor Medical kommenterar avtalet med Telix
6 marras 06.30
∙
Lehdistötiedote
TRMED: Thor Medical and Telix Pharmaceuticals sign strategic supply agreement for thorium-228
29 elo 05.15
∙
Lehdistötiedote
Thor Medical ASA interim results for 1H 2025 - strong operational and commercial progress
29 elo 05.00
∙
Lehdistötiedote
TRMED: Thor Medical and Oncoinvent Enter Strategic Thorium-228 Supply Agreement
22 elo 06.00
∙
Lehdistötiedote
Invitation to presentation of Thor Medical ASA's 1H 2025 on Friday 29 August at 08:00
4 elo 05.30
∙
Lehdistötiedote
TRMED: Thor Medical and AdvanCell expand strategic supply agreement for Thorium-228
1 elo 06.58
∙
Lehdistötiedote
Thor Medical ASA - Share capital increase in relation to Subsequent Offering is registered
4 heinä 08.41
∙
Lehdistötiedote
Thor Medical ASA: Final results of the Subsequent Offering
3 heinä 05.00
∙
Lehdistötiedote
Thor Medical ASA: The Subscription Period in the Subsequent Offering ends at 16:30 CEST today
26 kesä 12.33
∙
Lehdistötiedote
Thor Medical ASA: Primary insider notification and disclosure of large shareholdings
26 kesä 12.24
∙
Lehdistötiedote
Thor Medical ASA - Share capital increase in relation to the Private Placement and the PrimaryBid Offering is registered
26 kesä 05.00
∙
Lehdistötiedote
Thor Medical ASA: Commencement of the subscription period for the subsequent offering
25 kesä 16.58
∙
Lehdistötiedote
Thor Medical ASA: Registration of national prospectus and launch of subsequent offering
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Tuotteita joiden kohde-etuutena tämä arvopaperi
Sertifikaatit
2025 H1 -tulosraportti
96 päivää sitten38 min
Uutiset ja analyysit
Uutiset ja lehdistötiedotteet
Analyysit
28 marras 07.39
∙
Lehdistötiedote
BioStock: Thor Medical advances toward commercial scale following pilot success and major deal streak
28 marras 07.39
∙
Lehdistötiedote
BioStock: Thor Medical tar klivet mot kommersiell produktion efter framgångsrik pilot och intensiv avtalsperiod
20 marras 12.27
∙
Lehdistötiedote
Thor Medical ASA - New share capital registered
20 marras 06.30
∙
Lehdistötiedote
TRMED: Thor Medical enters supply agreement with NucliThera for thorium-228
18 marras 06.30
∙
Lehdistötiedote
TRMED: Thor Medical strengthens executive team to realise leadership ambitions in targeted alpha therapies
11 marras 22.15
∙
Lehdistötiedote
Thor Medical - Issuance of RSU shares to members of the board
7 marras 07.14
∙
Lehdistötiedote
BioStock: Thor Medical comments on the Telix agreement
7 marras 07.14
∙
Lehdistötiedote
BioStock: Thor Medical kommenterar avtalet med Telix
6 marras 06.30
∙
Lehdistötiedote
TRMED: Thor Medical and Telix Pharmaceuticals sign strategic supply agreement for thorium-228
29 elo 05.15
∙
Lehdistötiedote
Thor Medical ASA interim results for 1H 2025 - strong operational and commercial progress
29 elo 05.00
∙
Lehdistötiedote
TRMED: Thor Medical and Oncoinvent Enter Strategic Thorium-228 Supply Agreement
22 elo 06.00
∙
Lehdistötiedote
Invitation to presentation of Thor Medical ASA's 1H 2025 on Friday 29 August at 08:00
4 elo 05.30
∙
Lehdistötiedote
TRMED: Thor Medical and AdvanCell expand strategic supply agreement for Thorium-228
1 elo 06.58
∙
Lehdistötiedote
Thor Medical ASA - Share capital increase in relation to Subsequent Offering is registered
4 heinä 08.41
∙
Lehdistötiedote
Thor Medical ASA: Final results of the Subsequent Offering
3 heinä 05.00
∙
Lehdistötiedote
Thor Medical ASA: The Subscription Period in the Subsequent Offering ends at 16:30 CEST today
26 kesä 12.33
∙
Lehdistötiedote
Thor Medical ASA: Primary insider notification and disclosure of large shareholdings
26 kesä 12.24
∙
Lehdistötiedote
Thor Medical ASA - Share capital increase in relation to the Private Placement and the PrimaryBid Offering is registered
26 kesä 05.00
∙
Lehdistötiedote
Thor Medical ASA: Commencement of the subscription period for the subsequent offering
25 kesä 16.58
∙
Lehdistötiedote
Thor Medical ASA: Registration of national prospectus and launch of subsequent offering
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Since there are also (bad) attempts at pure misinformation from some here, I am pasting Investtech's automatic technical analyses which were updated yesterday 02.12.25. For those who are interested 😉
Automatic technical analysis. Short term, 2. Dec 2025
An approximately horizontal trend channel has been broken upwards in the short term. A continued strong development is indicated, and Thor Medical ASA now has support at any reactions down towards the trend lines. The stock has reached the objective at 4.41 kroner after a breakout from a rectangle formation. The price has now fallen back somewhat, but the formation indicates further upside. The stock has support at approximately 3.76 kroner and resistance at approximately 4.70 kroner. RSI above 70 shows that the momentum in the stock is strongly positive in the short term. Investors have consistently paid higher prices to buy the stock, which indicates increasing optimism and that the price will continue to rise. The stock is considered technically positive overall in the short term.
Recommendation one to six weeks' horizon: Buy (Score: 85)
Automatic technical analysis. Medium term, 2. Dec 2025
Thor Medical ASA shows strong development within a rising trend channel in the medium term. This signals increasing optimism among investors and indicates further price appreciation. The price has risen sharply after a buy signal from an inverse head-and-shoulders formation upon breaking above the resistance at 2.62 kroner. The objective at 3.74 kroner has now been reached, but the formation still signals development in the same direction. The stock is approaching resistance at approximately 4.70 kroner, which may lead to a downward reaction. A breakout above 4.70 kroner will, however, be a buy signal. Volume tops and volume bottoms correspond well with tops and bottoms in the price. This strengthens the trend picture. The RSI curve shows a rising trend, which supports the positive trend picture. The stock is considered technically positive overall in the medium term.
Recommendation one to six months' horizon: Buy (Score: 71)
There are still opinions about share issues and other matters concerning the company.
I recommend everyone who hasn't seen it to spend 15 minutes on Finansavisen-TV's interview with CEO Jasper Kurth from 29.08.25.
https://www.youtube.com/watch?v=RQL7eDEu4wg
Quoting a key point from the CEO:
"I think the most important message here is that we are fully funded to break even"
Good with a few percent discount, this one will go up and forward in the future now that they have entered into a 5-year agreement and have raised a lot of capital last year, so this should be good
The case is good and I don't think one needs to worry about it, so one shouldn't go on the defensive every time it dips a little, I think🤷♂️ Let it run its course, and this will become big.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Oslo Børs
Määrä
Osto
30 000
4,115
Myynti
Määrä
4,13
21 423
Viimeisimmät kaupat
Näytä enemmän
Aika
Hinta
Määrä
Ostaja
Myyjä
4,11
5 805
-
-
4,115
10 600
-
-
4,115
3 000
-
-
4,12
21 736
-
-
4,12
1 200
-
-
Ylin
4,345
VWAP
-
Alin
4,1
VaihtoMäärä
9,8 2 352 205
VWAP
-
Ylin
4,345
Alin
4,1
VaihtoMäärä
9,8 2 352 205
Tietoa osakekaupankäyntiin liittyvistä riskeistä
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Näytä kaikki
Seuraava tapahtuma
2025 Q4 -tulosraportti
26.2.2026
Menneet tapahtumat
2025 H1 -tulosraportti
29.8.
2024 H2 -tulosraportti
26.2.
2024 H1 -tulosraportti
30.8.2024
2023 H2 -tulosraportti
28.2.2024
2023 H1 -tulosraportti
31.8.2023
Datan lähde: Quartr, FactSet
Tuotteita joiden kohde-etuutena tämä arvopaperi
Sertifikaatit
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Since there are also (bad) attempts at pure misinformation from some here, I am pasting Investtech's automatic technical analyses which were updated yesterday 02.12.25. For those who are interested 😉
Automatic technical analysis. Short term, 2. Dec 2025
An approximately horizontal trend channel has been broken upwards in the short term. A continued strong development is indicated, and Thor Medical ASA now has support at any reactions down towards the trend lines. The stock has reached the objective at 4.41 kroner after a breakout from a rectangle formation. The price has now fallen back somewhat, but the formation indicates further upside. The stock has support at approximately 3.76 kroner and resistance at approximately 4.70 kroner. RSI above 70 shows that the momentum in the stock is strongly positive in the short term. Investors have consistently paid higher prices to buy the stock, which indicates increasing optimism and that the price will continue to rise. The stock is considered technically positive overall in the short term.
Recommendation one to six weeks' horizon: Buy (Score: 85)
Automatic technical analysis. Medium term, 2. Dec 2025
Thor Medical ASA shows strong development within a rising trend channel in the medium term. This signals increasing optimism among investors and indicates further price appreciation. The price has risen sharply after a buy signal from an inverse head-and-shoulders formation upon breaking above the resistance at 2.62 kroner. The objective at 3.74 kroner has now been reached, but the formation still signals development in the same direction. The stock is approaching resistance at approximately 4.70 kroner, which may lead to a downward reaction. A breakout above 4.70 kroner will, however, be a buy signal. Volume tops and volume bottoms correspond well with tops and bottoms in the price. This strengthens the trend picture. The RSI curve shows a rising trend, which supports the positive trend picture. The stock is considered technically positive overall in the medium term.
Recommendation one to six months' horizon: Buy (Score: 71)
There are still opinions about share issues and other matters concerning the company.
I recommend everyone who hasn't seen it to spend 15 minutes on Finansavisen-TV's interview with CEO Jasper Kurth from 29.08.25.
https://www.youtube.com/watch?v=RQL7eDEu4wg
Quoting a key point from the CEO:
"I think the most important message here is that we are fully funded to break even"
Good with a few percent discount, this one will go up and forward in the future now that they have entered into a 5-year agreement and have raised a lot of capital last year, so this should be good
The case is good and I don't think one needs to worry about it, so one shouldn't go on the defensive every time it dips a little, I think🤷♂️ Let it run its course, and this will become big.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Oslo Børs
Määrä
Osto
30 000
4,115
Myynti
Määrä
4,13
21 423
Viimeisimmät kaupat
Näytä enemmän
Aika
Hinta
Määrä
Ostaja
Myyjä
4,11
5 805
-
-
4,115
10 600
-
-
4,115
3 000
-
-
4,12
21 736
-
-
4,12
1 200
-
-
Ylin
4,345
VWAP
-
Alin
4,1
VaihtoMäärä
9,8 2 352 205
VWAP
-
Ylin
4,345
Alin
4,1
VaihtoMäärä
9,8 2 352 205
Tietoa osakekaupankäyntiin liittyvistä riskeistä
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.